Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to reposition the gastric acid pocket in GERD
NL-OMON26838Recruiting
- Sponsor
- Prof Dr G.E.E. Boeckxstaens Meibergdreef 9 1105 AZ Amsterdam [email protected]
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of azithromycin in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Prof Dr G.E.E. Boeckxstaens Meibergdreef 9 1105 AZ Amsterdam [email protected]. Primary endpoint: Rate of acid reflux episodes. Started Jan 2009; status: recruiting.
02
Drugs
azithromycin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON26838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26838.